More detailed data about HPGD gene mutation PHO patients with GI involvement need to be collected, and the underlying mechanism for the preference of mutation in SLCO2A1 in PHO patients with GI involvement awaits further studies. The gene discussed is SLCO2A1; the disease is primary hypertrophic osteoarthropathy.